Osteosarcopenia and Exercise

August 24, 2020 updated by: Selda Çiftci, Sisli Hamidiye Etfal Training and Research Hospital

The Impact of Combination of Aerobic and Resistive Exercise on Activities of Daily Living and Risk of Fall in Osteosarcopenic Patients

The purpose of this study is to assess the efficacy of combination of aerobic and resistive exercise on activities of daily living and risk of fall in osteosarcopenic patients

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

After being informed about the study and potential risk, all patients giving written informed consent will undergo study entry.

to begin with: assessment with bioelectrical body composition analyzer and first exercise and assessment clinical scales

1th month: assessment with bioelectrical body composition analyzer and assessment clinical scales 3th month: assessment with bioelectrical body composition analyzer and assessment clinical scales

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Sisli Hamidiye Etfal Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years to 91 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Over 70 years of age
  • Clinical diagnosis of osteoporosis or osteopenia
  • Independent mobilization
  • Walking speed < 0.8 m / sec
  • Grip strength < 20 kg for women, < 30 kg for men

Exclusion Criteria:

  • Uncontrolled hypertension (systolic blood pressure> 200 mmHg, diastolic blood pressure> 110 mmHg)
  • Uncontrolled diabetes mellitus
  • Stroke, hip fracture, knee and hip arthroplasty, spinal surgery in the last 6 months
  • Severe cardiac arrhythmia
  • Myocardial infarction in the last 6 months
  • Severe dementia and difficulties in cooperation
  • Cardiac pacemaker
  • Dialysis
  • Acute infection
  • Severe edema
  • Malignancy patients
  • Severe anemia (Hgb <8 mg / dl)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: exercise group
Female and male patients over 70 years of age with osteoporosis and sarcopenia
the combination of aerobic and resistive exercise, three time a week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline on Skeletal Muscle Mass Measurement at month 3
Time Frame: Baseline and Month 3
Assessment with bioelectrical body composition analyzer male: SMI<9,2 kg/m2 female: SMI<7,4 kg/m2
Baseline and Month 3
Change from Baseline on Skeletal Muscle Mass Measurement at month 1
Time Frame: Baseline and Month 1
Assessment with bioelectrical body composition analyzer male: SMI<9,2 kg/m2 female: SMI<7,4 kg/m2
Baseline and Month 1
Change from Baseline on Katz Activities of Daily Living Scale at month 3
Time Frame: Baseline and Month 3
minimum 0, maximum 6, high scores: better
Baseline and Month 3
Change from Baseline on Katz Activities of Daily Living Scale at month 1
Time Frame: Baseline and Month 1
minimum 0, maximum 6, high scores: better
Baseline and Month 1
Change from Baseline on Short Physical Performance Battery at month 3
Time Frame: Baseline and Month 3
0-low perfomance, 12-good performance
Baseline and Month 3
Change from Baseline on Short Physical Performance Battery at month 1
Time Frame: Baseline and Month 1
0-low perfomance, 12-good performance
Baseline and Month 1
Change from Baseline on Berg Balance Test at month 3
Time Frame: Baseline and Month 3
maximum 56 point, a score of < 45 indicates individuals may be at greater risk of falling.
Baseline and Month 3
Change from Baseline on Berg Balance Test at month 1
Time Frame: Baseline and Month 1
maximum 56 point, a score of < 45 indicates individuals may be at greater risk of falling.
Baseline and Month 1
Change from Baseline on Timed Up and Go Test at month 3
Time Frame: Baseline and Month 3
Stand up and walk 3 meters, turn around, walks back to the chair and sit down.14 seconds or longer : high risk for falling
Baseline and Month 3
Change from Baseline on Timed Up and Go Test at month 1
Time Frame: Baseline and Month 1
Stand up and walk 3 meters, turn around, walks back to the chair and sit down.14 seconds or longer : high risk for falling
Baseline and Month 1
Change from Baseline on Five Times Sit to Stand Test at month 3
Time Frame: Baseline and Month 3
Lower times: better scores
Baseline and Month 3
Change from Baseline on Five Times Sit to Stand Test at month 1
Time Frame: Baseline and Month 1
Lower times: better scores
Baseline and Month 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Figen Yılmaz, Sisli Hamidiye Etfal Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 3, 2018

Primary Completion (Actual)

March 3, 2019

Study Completion (Actual)

October 1, 2019

Study Registration Dates

First Submitted

August 19, 2020

First Submitted That Met QC Criteria

August 24, 2020

First Posted (Actual)

August 25, 2020

Study Record Updates

Last Update Posted (Actual)

August 25, 2020

Last Update Submitted That Met QC Criteria

August 24, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on exercise

Subscribe